Recent COVID-19 outbreaks, as well as the 2014-15 Ebola outbreaks, have provided us with invaluable experience and knowledge in disease response. Following the 2015 outbreak, we have developed our Athena mobile laboratories, which can be deployed all throughout the world.

The COVID-19 pandemic has changed the face of available diagnostic tools. It has enabled the rapid introduction of at-home testing with relatively easy "rapid" assays that can help determine if you have COVID-19. It has also enabled telemedicine in a way that was slow to emerge until COVID-19.

Getting tests in the hands of patients, and then enabling contact with a healthcare professional that can help manage your case, will improve healthcare worldwide, even in emerging countries with limited infrastructure.

We are currently working on at-home diagnostic assays that can test for a variety of viruses, including COVID. This may have a profound impact on health management for people with other comorbidities like diabetes and other autoimmune disorders.

There are so many more examples, like vaccines and therapeutics and the public response to them across the world.